Zero Coupon Pharmacy
Oak Brook, IL · 8 funds and programs
Fund sponsor
Zero Coupon Pharmacy of Oak Brook, IL is named on SEC Form D filings for 8 private funds and programs since 2012, most recently on Mar 7, 2019. Together they report $63.0M raised from 393 investor positions.
- Funds and programs
- 8Filed on Form D
- Total raised
- $63.0MCumulative sales reported on Form D, all funds
- Investor positions
- 393Summed across funds; one investor may be in several
- First fund
- Sep 2012Earliest first sale or filing
- Latest Form D
- Mar 7, 2019Most recent filing by any of its funds
- Latest fund's offering
- Rule 506(b)No general advertising
Real estate funds (8)
Fund
First sale
Raised
Investors
Minimum
Offering
Zero Coupon Pharmacy VIII DST
Oak Brook, IL
First saleNov 2017
Raised$11.9M
Investors84
Minimum$25K
Offering506(b)
Zero Coupon Pharmacy VII DST
Oak Brook, IL
First saleNov 2016
Raised$9.2M
Investors37
Minimum$25K
Offering506(b)
Zero Coupon Pharmacy VI DST
Chicago, IL
First saleNov 2016
Raised$9.7M
Investors40
Minimum$25K
Offering506(b)
Zero Coupon Pharmacy IV DST
Oak Brook, IL
First saleMar 2014
Raised$9.9M
Investors37
Minimum$25K
Offering506(b)
Zero Coupon Pharmacy V DST
Oak Brook, IL
First saleMar 2014
Raised$7.9M
Investors46
Minimum$25K
Offering506(b)
Zero Coupon Pharmacy III DST
Oak Brook, IL
First saleOct 2013
Raised$4.9M
Investors54
Minimum$25K
Offering506(b)
Zero Coupon Pharmacy II DST
Oak Brook, IL
First saleAug 2013
Raised$5.1M
Investors51
Minimum$25K
Offering506(b)
Zero Coupon Pharmacy DST
Oak Brook, IL
First saleSep 2012
Raised$4.4M
Investors44
Minimum$25K
Offering—
Grouped by AltMountain from the company named on each Form D and the funds' names, so the list may be incomplete or include a related fund. New programs are added automatically when they file. Request a correction
From SEC filings, not verified. This page summarizes Form D filings as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the sponsor or its funds. “Raised” is cumulative sales, not current assets or performance. Full disclosures